Loading...
Explore More at wakehealth.edu

Clinical and Translational Science Institute

Keywords
Last Name

Nancy M.P. King, J.D.

TitleProfessor
InstitutionWake Forest School of Medicine
DepartmentPHS-Social Sciences
Address
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionWake Forest School of Medicine
    DepartmentInstitute for Regenerative Medicine


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Andrews JE, Moore JB, Weinberg RB, Sissine M, Gesell S, Halladay J, Rosamond W, Bushnell C, Jones S, Means P, King NMP, Omoyeni D, Duncan PW. Ensuring respect for persons in COMPASS: a cluster randomised pragmatic clinical trial. J Med Ethics. 2018 Aug; 44(8):560-566. PMID: 29720489.
      View in: PubMed
    2. Robeson R, King NMP. Performable Case Studies in Ethics Education. Healthcare (Basel). 2017 Sep 12; 5(3). PMID: 28895903.
      View in: PubMed
    3. Hall MA, King NM. Conscience, Courage, and "Consent". Hastings Cent Rep. 2016 Mar-Apr; 46(2):30-2. PMID: 27120282.
      View in: PubMed
    4. Shepherd L, Macklin R, King NM, Dreger A, Wages NA. Informed Consent for Research on Medical Practices. Ann Intern Med. 2015 Nov 03; 163(9):725. PMID: 26524576.
      View in: PubMed
    5. Baker HB, McQuilling JP, King NM. Ethical considerations in tissue engineering research: Case studies in translation. Methods. 2016 Apr 15; 99:135-44. PMID: 26282436.
      View in: PubMed
    6. Friedmann T, Jonlin EC, King NMP, Torbett BE, Wivel NA, Kaneda Y, Sadelain M. ASGCT and JSGT Joint Position Statement on Human Genomic Editing. Mol Ther. 2015 Aug; 23(8):1282. PMID: 26227250.
      View in: PubMed
    7. King NM. The importance of amicable and productive disagreement. J Med Philos. 2015 Jun; 40(3):286-8. PMID: 25870308.
      View in: PubMed
    8. King NM. Commentary on Wilson et al. Clin Trials. 2014 Oct; 11(5):530-1. PMID: 25190027.
      View in: PubMed
    9. King NM, Iltis AS. Cell-based interventions in utero: time to reconsider. Front Pharmacol. 2014; 5:214. PMID: 25278899.
      View in: PubMed
    10. King NM, Perrin J. Ethical issues in stem cell research and therapy. Stem Cell Res Ther. 2014 Jul 07; 5(4):85. PMID: 25157428.
      View in: PubMed
    11. Robeson R, King NM. Loss of possession: concussions, informed consent, and autonomy. J Law Med Ethics. 2014; 42(3):334-43. PMID: 25264091.
      View in: PubMed
    12. Freedman BI, Fletcher AJ, Sanghani VR, Spainhour M, Graham AW, Russell GB, Cooke Bailey JN, Iltis AS, King NM. Perceptions regarding genetic testing in populations at risk for nephropathy. Am J Nephrol. 2013; 38(6):453-7. PMID: 24280773.
      View in: PubMed
    13. Macklin R, Shepherd L, Dreger A, Asch A, Baylis F, Brody H, Churchill LR, Coleman CH, Cowan E, Dolgin J, Downie J, Dresser R, Elliott C, Epright MC, Feder EK, Glantz LH, Grodin MA, Hoffman W, Hoffmaster B, Hunter D, Iltis AS, Kahn JD, King NM, Kraft R, Kukla R, Leavitt L, Lederer SE, Lemmens T, Lindemann H, Marshall MF, Merz JF, Miller FH, Mohrmann ME, Morreim H, Nass M, Nelson JL, Noble JH, Reis E, Reverby SM, Silvers A, Sousa AC, Spece RG, Strong C, Swazey JP, Turner L. The OHRP and SUPPORT--another view. N Engl J Med. 2013 Jul 11; 369(2):e3. PMID: 23803134.
      View in: PubMed
    14. King NM, Robeson R. Athletes are Guinea pigs. Am J Bioeth. 2013; 13(10):13-4. PMID: 24024797.
      View in: PubMed
    15. King NM. There's a lot we don't know (and we ought to say so). Am J Bioeth. 2013; 13(12):20-1. PMID: 24256525.
      View in: PubMed
    16. Churchill LR, King NM, Henderson GE. Why we should continue to worry about the therapeutic misconception. J Clin Ethics. 2013; 24(4):381-6. PMID: 24597426.
      View in: PubMed
    17. Corrigan-Curay J, Cohen-Haguenauer O, O'Reilly M, Ross SR, Fan H, Rosenberg N, Somia N, King N, Friedmann T, Dunbar C, Aiuti A, Naldini L, Baum C, von Kalle C, Kiem HP, Montini E, Bushman F, Sorrentino BP, Carrondo M, Malech H, Gahrton G, Shapiro R, Wolff L, Rosenthal E, Jambou R, Zaia J, Kohn DB. Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy. Mol Ther. 2012 Jun; 20(6):1084-94. PMID: 22652996.
      View in: PubMed
    18. King NM. Research is care. Hastings Cent Rep. 2012 May-Jun; 42(3):7. PMID: 22670289.
      View in: PubMed
    19. Henderson GE, Juengst ET, King NM, Kuczynski K, Michie M. What research ethics should learn from genomics and society research: lessons from the ELSI Congress of 2011. J Law Med Ethics. 2012; 40(4):1008-24. PMID: 23289702.
      View in: PubMed
    20. King NM. Nanomedicine first-in-human research: challenges for informed consent. J Law Med Ethics. 2012; 40(4):823-30. PMID: 23289684.
      View in: PubMed
    21. King NM, Iltis AS. Introduction: research ethics: reexamining key concerns. J Law Med Ethics. 2012; 40(4):865-6. PMID: 23289689.
      View in: PubMed
    22. Fatehi L, Wolf SM, McCullough J, Hall R, Lawrenz F, Kahn JP, Jones C, Campbell SA, Dresser RS, Erdman AG, Haynes CL, Hoerr RA, Hogle LF, Keane MA, Khushf G, King NM, Kokkoli E, Marchant G, Maynard AD, Philbert M, Ramachandran G, Siegel RA, Wickline S. Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging field. J Law Med Ethics. 2012; 40(4):716-50. PMID: 23289677.
      View in: PubMed
    23. Walker RL, King NM. Biodefense research and the U.S. regulatory structure whither nonhuman primate moral standing? Kennedy Inst Ethics J. 2011 Sep; 21(3):277-310. PMID: 22073818.
      View in: PubMed
    24. Kent A, King NM, Cohen-Haguenauer O. Toward a proportionate regulatory framework for gene transfer: a patient group-led initiative. Hum Gene Ther. 2011 Feb; 22(2):126-34. PMID: 20942607.
      View in: PubMed
    25. Hall MA, Friedman JY, King NM, Weinfurt KP, Schulman KA, Sugarman J. Commentary: Per capita payments in clinical trials: reasonable costs versus bounty hunting. Acad Med. 2010 Oct; 85(10):1554-6. PMID: 20881671.
      View in: PubMed
    26. Hall MA, King NM, Perdue LH, Hilner JE, Akolkar B, Greenbaum CJ, McKeon C. Biobanking, consent, and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium. Clin Trials. 2010; 7(1 Suppl):S33-45. PMID: 20693188.
      View in: PubMed
    27. Weinfurt KP, Hall MA, King NM, Friedman JY, Schulman KA, Sugarman J. Disclosure of financial relationships to participants in clinical research. N Engl J Med. 2009 Aug 27; 361(9):916-21. PMID: 19710491.
      View in: PubMed
    28. King NM. Benefits, harms, and motives in clinical research. Hastings Cent Rep. 2009 Jul-Aug; 39(4):3. PMID: 19711622.
      View in: PubMed
    29. King NM, Cohen-Haguenauer O. En route to ethical recommendations for gene transfer clinical trials. Mol Ther. 2008 Mar; 16(3):432-8. PMID: 18297094.
      View in: PubMed
    30. Henderson GE, Churchill LR, Davis AM, Easter MM, Grady C, Joffe S, Kass N, King NM, Lidz CW, Miller FG, Nelson DK, Peppercorn J, Rothschild BB, Sankar P, Wilfond BS, Zimmer CR. Clinical trials and medical care: defining the therapeutic misconception. PLoS Med. 2007 Nov 27; 4(11):e324. PMID: 18044980.
      View in: PubMed
    31. King NM. The ethics of genetic testing: is more always better? N C Med J. 2007 Mar-Apr; 68(2):112-4. PMID: 17566556.
      View in: PubMed
    32. Easter MM, Henderson GE, Davis AM, Churchill LR, King NM. The many meanings of care in clinical research. Sociol Health Illn. 2006 Sep; 28(6):695-712. PMID: 17184413.
      View in: PubMed
    33. Kipnis K, King NM, Nelson RM. An open letter to institutional review boards considering Northfield Laboratories' PolyHeme trial. Am J Bioeth. 2006 May-Jun; 6(3):18-21. PMID: 16754441.
      View in: PubMed
    34. Kipnis K, King NM, Nelson RM. Trials and errors: barriers to oversight of research conducted under the emergency research consent waiver. IRB. 2006 Mar-Apr; 28(2):16-9. PMID: 16770884.
      View in: PubMed
    35. King NM. Protection of human subjects and scientific progress: can the two be reconciled? Hastings Cent Rep. 2006 Jan-Feb; 36(1):6-7; author reply 8-9. PMID: 16544828.
      View in: PubMed
    36. Henderson GE, Easter MM, Zimmer C, King NM, Davis AM, Rothschild BB, Churchill LR, Wilfond BS, Nelson DK. Therapeutic misconception in early phase gene transfer trials. Soc Sci Med. 2006 Jan; 62(1):239-53. PMID: 16000230.
      View in: PubMed
    37. King NM, Henderson GE, Churchill LR, Davis AM, Hull SC, Nelson DK, Parham-Vetter PC, Rothschild BB, Easter MM, Wilfond BS. Consent forms and the therapeutic misconception: the example of gene transfer research. IRB. 2005 Jan-Feb; 27(1):1-8. PMID: 15835063.
      View in: PubMed
    38. Henderson GE, Davis AM, King NM, Easter MM, Zimmer CR, Rothschild BB, Wilfond BS, Nelson DK, Churchill LR. Uncertain benefit: investigators' views and communications in early phase gene transfer trials. Mol Ther. 2004 Aug; 10(2):225-31. PMID: 15294169.
      View in: PubMed
    39. Henderson GE, Davis AM, King NM. Vulnerability to influence: a two-way street. Am J Bioeth. 2004; 4(3):50-2; discussion W32. PMID: 16192139.
      View in: PubMed
    40. Churchill LR, Nelson DK, Henderson GE, King NM, Davis AM, Leahey E, Wilfond BS. Assessing benefits in clinical research: why diversity in benefit assessment can be risky. IRB. 2003 May-Jun; 25(3):1-8. PMID: 14569987.
      View in: PubMed
    41. King NM. Accident & desire. Inadvertent germline effects in clinical research. Hastings Cent Rep. 2003 Mar-Apr; 33(2):23-30. PMID: 12760117.
      View in: PubMed
    42. King NM. The line between clinical innovation and human experimentation. Seton Hall Law Rev. 2003; 32(3):571-80. PMID: 12741413.
      View in: PubMed
    43. King NM. RAC oversight of gene transfer research: a model worth extending? J Law Med Ethics. 2002; 30(3):381-9. PMID: 12497698.
      View in: PubMed
    44. King NM, Henderson G. Treatments of last resort: informed consent and the diffusion of new technology. Mercer Law Rev. 1991; 42(3):1007-50. PMID: 11651433.
      View in: PubMed
    45. Havighurst CC, King NM. Liver transplantation in Massachusetts: public policymaking as morality play. Indiana Law Rev. 1986; 19(4):955-87. PMID: 11650768.
      View in: PubMed
    46. King NM. Health policy--ensuring informed consent in human experimentation: a comparison of the approaches of two states. North Carol Law Rev. 1979 Oct; 58(1):137-52. PMID: 11661816.
      View in: PubMed
    King's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _